Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Sell
42,012
-14,175
-25% -$371K 0.09% 234
2026
Q1
$1.58M Buy
56,187
+31,054
+124% +$827K 0.27% 58
2025
Q4
$626K Buy
+25,133
New +$634K 0.18% 101

Other funds holding PFE

Frec Markets Inc's PFE Position: Q2 2026 in Review

Frec Markets Inc reduced its Pfizer (PFE) stake by 25% in Q2 2026, selling an estimated $371K and leaving 42,012 shares worth $1.01M. The position accounts for 0.09% of the portfolio, ranked #234.

Frec Markets Inc first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.58M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Frec Markets Inc held 42,012 shares of Pfizer worth $1.01M as of Q2 2026.
  • Frec Markets Inc sold 14,175 Pfizer shares in Q2 2026, an estimated $371K.
  • Pfizer made up 0.09% of Frec Markets Inc's portfolio in Q2 2026, its #234 holding.
  • Frec Markets Inc first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Frec Markets Inc's Pfizer position peaked at $1.58M in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Frec Markets Inc's 13F filing for Q2 2026, filed 13 Aug 2026.